Listeria: Spinach and mixed leaves recalled due to detection
The Spinach and mixed leaves products are branded under the McCormack Family Farms name as well as Tesco, Egan's and Supervalu.Retailers have been asked to remove the implicated products from sale and display recall notices at point-of-sale.Consumers are advised not to eat the implicated products.McCormack Family Farms have been approached for comment.
Last week, 141 ready-made products were recalled "due to a link with the outbreak".The various branded prepared meals and side dishes are produced by Ballymaguire Foods and are sold in many supermarkets in the country, including Tesco, Aldi, Centra and Supervalu.In a statement, Ballymaguire Foods, which is based in Dublin, said it initiated a "full precautionary recall of all products produced at one of our facilities following the identification of listeria bacteria as part of a quality control check".The company apologised to customers.
What is listeria?
Listeria infection is an illness caused by bacteria that can spread through food.Another name for the illness is listeriosis.It can be very serious for pregnant women, people over the age of 65, and those with weakened immune systems.Symptoms of Listeria monocytogenes infection can include mild flu-like symptoms or gastrointestinal symptoms such as nausea, vomiting, and diarrhoea.In rare cases, the infection can become more severe, leading to serious complications.The incubation period (the time between initial infection and the first appearance of symptoms) averages about three weeks, but can range from three to 70 days.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
16 minutes ago
- The Independent
Should you be taking cod liver oil supplements? Health benefits explained
Cod liver oil boasts a host of health benefits and has been used since the 18th century as a means of supplementing the body with vital vitamin D – a nutrient that nearly everyone in the UK is deficient in. But fish oil has other benefits, too. As the name suggests, cod liver oil is extracted from the liver of cod fish, which might not sound all that appealing but there are plenty of reasons to take it. 'Cod liver oil is a popular choice because it's rich in omega-3 fatty acids, vitamin D and vitamin A, all of which support heart health, brain function, immunity and skin health,' explains nutritionist Alexa Mullane. 'The omega-3 fatty acids also support cognitive performance, reduce inflammation, and may even help combat mood disorders like anxiety and depression.' People looking to improve cardiovascular health, strengthen bones, or boost cognitive function may find cod liver oil particularly useful. However, pregnant women should avoid cod liver oil due to its high vitamin A content. Omega-3s are found mainly in fish, but they can also be found in some nuts, in algae and in flaxseed. Experts recommend consuming two portions of fish a week in order to get enough fatty acids into your diet, but this can be tricky, especially if you don't enjoy eating fish. Keep reading for everything you need to know about cod liver oil, including what it is, the benefits and the supplements to buy. What is cod liver oil? Cod liver oil is one of the most effective sources of vitamins A and D and omega-3 in one supplement. Your body can't naturally produce some of the main components of omega-3 fatty acids, namely eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), so taking a supplement can help top up the concentration in your body to support your health. The vitamin D in cod liver oil helps to regulate phosphate and calcium in the body which contributes to healthy muscles, bones and teeth. The body can make vitamin D when it's exposed to sunlight, but according to experts, most people living in the UK struggle to get adequate sun exposure and are vitamin D deficient. Vitamin A, also known as retinol, helps the body to metabolise iron and supports eye health and the quality of your skin. It's also vital for immunity and maintaining your body's natural defences against infections and diseases. You'll find vitamin A in green leafy vegetables and dairy, along with some root vegetables like sweet potato and squash. It's also in orange foods like carrots, mangoes and apricots. What are the benefits of cod liver oil supplements? Cod liver oil supplements are great for anyone who struggles to maintain a balanced, vitamin-rich diet or who worries about a lack of vitamin D, but it's also recommended to fortify the body as it naturally ages. As we grow older, our bodies face new challenges, especially in regards to things like the quality of our joints, our vision and our cognitive abilities. Supplementing cod liver oil, which contains the powerful antioxidants A and D, can help with neutralising free radicals and encouraging new healthy cell turnover. It can also help reduce inflammation in the body. Omega-3 can suppress the proteins that cause inflammation, lessening pain and swelling, promoting a better healing process and reducing the likelihood of infections. As we age, our bones and joints may also suffer as cartilage breaks down and bones become weaker. The vitamin D in cod liver oil can help the body absorb calcium effectively and prevent the rate of bone loss. This can lessen the risk of a serious injury if you fall and help support tooth health in later life, too. Some studies suggest that cod liver oil could also reduce joint pain and improve symptoms of rheumatoid arthritis. The ageing process can also affect the quality of your vision, something that vitamin A is essential for. Omega-3s have also been shown to reduce the risk of eye conditions. However, the most significant area of the body that omega-3 is shown to benefit is the heart. This is because fatty acids have the potential to reduce blood triglycerides – fat stored in the blood – and raise good cholesterol. People of all ages could benefit from taking a cod liver oil supplement daily, but despite the many positive impacts, these supplements aren't a substitute for a balanced diet. You should still aim to eat fish twice a week and get adequate vitamin D and A from the foods you eat. It can be difficult to get enough omega-3 from a vegan diet, but it is possible, and fish-free supplements can be an important part of maintaining a healthy lifestyle when you decide to go plant-based. Which fish oil should I choose? 'Cod liver oil and omega-3 supplements both provide essential fatty acids, but cod liver oil offers additional nutrients like naturally occurring vitamins A and D, which support immune function, vision, and bone health,' explains Mullane. 'Omega-3 supplements, mostly derived from fish or algae, will usually have higher levels of EPA and DHA and are often made from different types of oily fish such as sardines, anchovies and mackerel.' Cod liver oil is considered a bit of a super supplement because it contains so many nutrients, however, there is a risk of overloading your body if you're taking it at the same time as other supplements that contain Vitamin A and Vitamin D, so it's worth bearing this in mind. 'Fish oil (purely omega-3 with no added vitamins) is a great choice for heart and brain health without worrying about vitamin A toxicity or doubling up if you're already taking a vitamin D supplement,' explains nutritionist Claire Johnson. 'Cod liver oil may be useful for those needing extra vitamin A or D, but it's always worth checking this first with your GP, especially if you're trying to conceive or pregnant.' Johnson adds that 'since the liver filters toxins, cod liver oil may have a higher risk of contamination from environmental pollutants like heavy metals. To stay safe, choose a high-quality supplement. Whether you decide on cod liver oil or fish oil, choose from a reputable brand that publishes purity test results. My favourite fish oil brand is Bare Biology, which tests its products for purity and quality, with five-star purity and quality ratings from International Fish Oil Standards.' You might also consider taking krill oil, which is also derived from fish and offers a high dose of Omega-3 fatty acids but contains astaxanthin – a powerful antioxidant that can benefit heart health. If you're looking for a vegan alternative to fish oil, there are many options made from algae, walnuts or flaxseeds. The nutrients in microalgae are actually consumed by the fish that make cod liver oil, and in comparison to Omega-3 alternatives made from hemp or flaxseed, the bioavailability is considered to be much better. 'If you want omega-3 benefits without the extras, go for a high-quality fish oil or algae-based supplement for a plant-based option. If you need extra vitamin A and D, cod liver oil can be a useful addition, but proceed with caution. As always, your individual needs should dictate your choice,' says Johnson. 'Cod liver oil is ideal for those seeking a broader nutrient profile, while pure omega-3 supplements may be preferable for those who need higher doses of EPA and DHA without excess vitamin A. Look for cod liver oil brands that use wild fish instead of farmed fish, sustainable practices, and are tested for purity. I like Wiley's Finest wild norwegian cod liver oil, Nordic Naturals cod liver oil, Zinzino fish oil adds Mullane.
Telegraph
2 hours ago
- Telegraph
New drug could halt Alzheimer's
A new drug could halt the progression of Alzheimer's disease. Trials suggest the treatment, called trontinemab, could be the most powerful weapon yet against dementia. Research will now examine whether the drug should be given to those without any symptoms in order to prevent the disease. Results presented at the Alzheimer's Association International Conference in Toronto found the 'game-changing' treatment can clear the devastating plaques associated with Alzheimer's far more rapidly than any current licensed drug. Nine in 10 patients prescribed trontinemab experienced amyloid clearance within 28 weeks, meaning visible markers of disease had vanished. Experts hope these changes will be matched by improvements in memory and functioning, with an 18-month trial of 1,600 patients now under way. Separate research will examine whether the drug could be given to people without any signs of dementia, in the same way that statins are used to ward off heart disease. On Monday, experts said the findings were 'very promising', suggesting that the drug was much more powerful than existing medications, with far fewer side effects. Around one million people in the UK suffer from dementia, with Alzheimer's disease the most common form. Powerful precise effects at low doses Trontinemab is one of a class of new medicines aimed at clearing amyloid plaques. The new findings from phase two trials suggest that, in less than seven months, it has outperformed the ability of existing drugs to clear plaques in 18 months. Experts hope that if given early enough, the drug could save some patients from developing symptoms at all. It has been engineered to more easily cross the blood-brain barrier, meaning it can ensure powerful precise effects at low doses. The lack of side effects means it could be offered to large populations. This also means it could be offered at a far lower price than current medications, which require intense monitoring, including regular scans. Experts believe it could become the first Alzheimer's drug to be funded by the NHS. Last year, medicines regulators in the UK gave the green light to the first two treatments found to slow progression of Alzheimer's disease. Both lecanemab and donanemab use monoclonal antibodies to clear amyloid plaques in Alzheimer's disease. In trials they have been found to slow decline by 27 per cent and 35 per cent respectively, over 18 months. However, the risk of brain swelling and brain bleeds means they need intense monitoring. The new drug appears to have a far better safety profile. The phase two trial of 149 patients found less than five per cent of cases suffering amyloid-related imaging abnormalities, and all cases quickly resolved. It also requires less frequent infusions, with mass trials to examine the impact of giving the drug to patients once a month for six months, then every three months. Scientists have been intrigued by the promise of trontinemab because of the way it has been designed to be transported across the blood brain-barrier, which normally prevents chemicals in the bloodstream from entering the brain. 'Game-changing' Prof Sir John Hardy,the chairman of molecular biology of neurological disease at University College London's Institute of Neurology said the advance could be 'game-changing'. He told The Telegraph: 'This is absolutely great news. It sucks the plaque out of the brain really quickly, much faster than we have seen with lecanemab or donanemab.' The scientist, who was the first to identify the role of amyloid in the disease, said the drug's safety profile was a 'massive improvement' on the current drugs on the market, raising hopes it could be used both to prevent disease and stop it in its tracks. He said: 'There is no doubt this could be game-changing. We hope that if we can use these drugs to people early, we can halt the progression of disease, even before people have symptoms. Now we need to see the size of the clinical effect.' Neither of the current drugs have been funded by the NHS as a result of their high costs, much of which stems from the need for intense monitoring, including regular scans. Prof Hardy said: 'These results show it is much faster and safer than previous drugs, which means less monitoring. That brings down the cost significantly, it means fewer MRI scans, so that would surely mean it would get Nice [National Institute of Health and Care Excellence] approval.' 'Very promising evidence' Prof Jonathan Schott, the chief medical officer at Alzheimer's Research UK said: 'We urgently need a range of treatments for Alzheimer's that are effective and safe for the people affected by this devastating disease. 'Evidence presented at the Alzheimer's Association conference in Toronto on trontinemab is very promising, showing that the drug can effectively and rapidly clear amyloid from the brain, seemingly with very few side effects. 'We now need to see whether these early stage results carry through to later stage clinical trials, which are planned to start later this year, including in the UK. These trials will show whether the drug is not only safe, but impacts on memory, thinking and quality of life.' He said it was 'exciting' that the drug would now be tested in some people without symptoms under the phase three trials. Levi Garraway, Roche's chief medical officer said: 'Combining new treatment avenues with advanced diagnostics may enable earlier and potentially more effective intervention. 'With plans for phase three trials in both early symptomatic and preclinical Alzheimer's disease, we are advancing science with the goal of delaying – and ultimately preventing – progression of this devastating condition.'
The Sun
2 hours ago
- The Sun
Michael Smith health update as former darts world champion forced to undergo blood tests and withdraw from tournament
MICHAEL SMITH has been forced to undergo blood tests and withdraw from tournaments amid ongoing health problems. The former world champion is set to miss Players Championships 22 and 23 and European Tour 11 and 12. 1 Smith has already been ruled out of the World Matchplay following a spate of injuries and illness issues. And it threatens to see him also miss the World Grand Prix and European Championship. Smith has arthritis in his throwing hand, problems with his foot and ankle as well as an ongoing shoulder injury. Darting Promotions said in a statement: "We have become aware over the last few days of reports/comments on social media regarding Michael and his participation in events in the near future. "Ourselves and Michael would like to provide a short update on the injuries which have been affecting him in recent months and assure fans that he will be back fully fit very soon. "As you are all aware Michael has been suffering with arthritis in his right hand for a while and has recently developed a problem with his left foot/ankle. "After recent blood tests this has revealed certain answers and we are now hopeful that with a course of medication these problems can be controlled in the future. "As you will have seen Michael has withdrawn from this week's events in Germany, this is due to him requiring a scan on his shoulder which was damaged at Christmas time. "This has been arranged for this week which unfortunately means he is unable to take part in the upcoming Pro Tours and European Tour qualifiers. "We feel this is now the right time to hopefully resolve the above issues and allow Michael to get back to his best and be back playing the way we all know he can." Smith, 34, revealed in January that he has had arthritis issues since he was a teenager. He said: "Feel like this is needed to be said as I'm annoyed seeing I'm finished or what's happening it's this or that. "The last 6 weeks I've had a grade 2 AC shoulder injury and seeking physio every 2/3 days to help that but for 3/4 years I've been fighting something else. "I broke both my wrists when I was 19 and now it's catching up with me and now suffering with arthritis to my right hand. "This isn't sympathy or a cry for help. This is letting you all in to it. I've never give up or stopped from any pain. "I played a world final with a broken hand. I made a UK Open final with a hole in my groin. I've won Pro Tours and Euros with problems with my ankle. "What this statement means is this is me opening up and letting you all know. "I didn't say earlier as I was scared of losing the Premier League or losing World Series but I wasn't picked anyway so why not now. "I see the specialist Monday and when I know you will know what will happen over the next month or so. "I'll never let anything beat me and I promise I'll be back very VERY quickly."
